TITLE

Tissue-dilating sheath receives FDA premarket clearance

PUB. DATE
February 2010
SOURCE
Cardiology Today;Feb2010, Vol. 13 Issue 2, p17
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on a 510(k) clearance from the U.S. Food and Drug Administration (FDA) received by Spectranetics for its VisiSheath Dilator Sheath indicated for the percutaneous dilation of tissue surrounding cardiac leads.
ACCESSION #
47733206

 

Related Articles

  • Spectranetics LLD granted Japanese approval.  // Medical Device Daily;4/7/2011, Vol. 15 Issue 67, p6 

    The article reports that the Japanese Ministrty of Health has approved the use of the LLD lead locking device manufactured by Spectranetics which is used for removing pacemaker and defibrillator cardiac leads.

  • FDA SETS ADVISORY PANEL DATE OF OCTOBER 2 FOR LACI REVIEW.  // Biotech Equipment Update;Oct2003, p6 

    Colorado Springs, Colorado-based medical device manufacturer Spectranetics Corp. has announced that the FDA has set the date of October 2, 2003 for a Circulatory System Devices Advisory Panel review of the company's Pre-Market Approval (PMA) Supplement based on its Laser Angioplasty to treat...

  • SPECTRANETICS REPORTS SUCCESS OF EXCIMER LASER FOR VEIN GRAFTS.  // Biotech Equipment Update;Nov2003, p4 

    The Spectranetics Corp. has announced results from the CORAL LAKE registry, a single-center, retrospective registry that studied the use of the excimer laser for the treatment of degenerated saphenous vein grafts. CORAL LAKE included 119 patients treated with the excimer laser at Lakeland...

  • Agreements/contracts.  // Medical Device Daily;7/20/2011, Vol. 15 Issue 134, p3 

    The article reports on the appointment of Clinipace Worldwide by Spectranetics for the management of its pivotal cardiovascular device clinical trial.

  • Product Pipeline.  // Cardiovascular Devices & Drugs;Jun2009, Vol. 15 Issue 6, p23 

    The article reports that the Spectranetics laser sheath from Spectranetics is safe and effective, according to its Lead Extraction in Contemporary Settings (LExICon) study. It is noted that the laser sheath utilizes low temperature ultraviolet light to ablate scar tissue with safety and...

  • Industry Pipeline.  // Ocular Surgery News;3/25/2010, Vol. 28 Issue 6, p40 

    The article offers information on the approval process of several ophthalmic drugs and equipment, including the MA09-hRPE cells from Advanced Cell Technology Inc., the TearLab Osmolority System from OcuSense and the Lucentis ranibizumab injection from Genentech.

  • Lead extraction highlighted at this year's HRS meeting. HAIMOVITCH, LARRY // Medical Device Daily;5/19/2010, Vol. 14 Issue 96, p1 

    The article discusses the highlights of the 2010 meeting of the Heart Rhythm Society (HRS) held in Denver, Colorado. Majority of papers, posters and sessions at the event focused on lead extraction. Spectranetics, in partnership with Medical Simulation Corp., presented its advanced laser lead...

  • International report. Brosky, John // Diagnostics & Imaging Week;7/2/2009, Vol. 12 Issue 26, p1 

    This section offers news briefs related to diagnostics technology. Siemens Healthcare celebrates the 500th installation of a Somaton dual-source computed tomography (CT) scanner which was introduced several years ago. A CE-mark approval was received by Spectranetics for its next-generation...

  • Leg Men. Stone, Andy // Forbes Asia;11/13/2006, Vol. 2 Issue 19, p106 

    The article focuses on Spectranetics Corp. which has developed the so-called cardiovascular excimer laser. The medical device shoots a powerful beam, up to 2.5 millimeters in diameter, that cuts through cholesterol plaque. Spectranetics CEO John Schulte is in the battle to get his machine into...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics